ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc (CERO)

0.115
-0.0765
(-39.95%)
終了 12月7日 6:00AM
0.12
0.005
(4.35%)
取引時間後: 9:05AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
0.12
買値
0.1199
売値
0.12
出来高
37,960,877
0.1126 日の範囲 0.18
0.0636 52 週間の範囲 12.38
前日終値
0.1915
始値
0.174
最終取引時間
平均取引量 (3 か月)
69,826,169
財務取引量
US$ 4,991,582
VWAP
0.131493

CERO 最新ニュース

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

SOUTH SAN FRANCISCO, Calif, Dec. 06, 2024 (GLOBE NEWSWIRE) --   CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an...

CERo Therapeutics, Inc. Provides Corporate Update

Company announces submission of IND Clinical Hold Complete Response Letter SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236

Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN FRANCISCO, Calif., Sept. 25, 2024 (GLOBE...

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq:...

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) --  CERo...

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0762-38.83792048930.19620.20980.114657792400.1835058CS
40.049469.97167138810.07060.44770.06521906058730.24070053CS
120.034740.67995310670.08530.44770.0636698261690.2240067CS
26-0.87-87.87878787880.991.020.0636351290050.22415974CS
52-5.13-97.71428571435.2512.380.0636222095400.26732521CS
156-5.13-97.71428571435.2512.380.0636222095400.26732521CS
260-5.13-97.71428571435.2512.380.0636222095400.26732521CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
UPCUniverse Pharmaceuticals Inc
US$ 3.38
(221.90%)
92.97M
LIFWMSP Recovery Inc
US$ 3.2461
(104.16%)
29.04M
GXAIGaxos ai Inc
US$ 2.5801
(81.70%)
145.58M
SBETSharpLink Gaming Inc
US$ 0.9116
(73.97%)
27.04M
HCTIHealthcare Triangle Inc
US$ 1.165
(68.38%)
4.33M
ORISOriental Rise Holdings Ltd
US$ 3.6833
(-93.42%)
27.43M
LICNLichen China Limited
US$ 0.4895
(-76.91%)
185.75M
MYNAMynaric AG
US$ 0.499246
(-64.59%)
3.58M
CEROCERo Therapeutics Holdings Inc
US$ 0.1146
(-40.16%)
37.62M
BTCTBTC Digital Ltd
US$ 10.50
(-32.95%)
3.25M
SMXSMX Security Matters Public Company
US$ 0.4879
(64.06%)
439.56M
SOUNSoundHound AI Inc
US$ 15.01
(12.60%)
215.53M
LICNLichen China Limited
US$ 0.4895
(-76.91%)
185.75M
NVDANVIDIA Corporation
US$ 142.44
(-1.81%)
185.13M
SVMHSRIVARU Holding Ltd
US$ 0.0293
(-16.29%)
159.56M

CERO Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock